Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Jorge I. Portuondo

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0003-1639-115X; OpenAlex author ID A5082342604.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 2, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Top advances of the year: Neoadjuvant therapy in pancreatic cancer. First author DOI 10.1002/cncr.70431↗
  2. Nodal downstaging as a treatment goal for node-positive pancreatic cancer. First author DOI 10.1016/j.surg.2018.12.009↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Matthew H. G. Katz · 1 shared paper, 2026
  2. Nader Nabile Massarweh · 1 shared paper, 2019
  3. Hop S. Tran Cao · 1 shared paper, 2019

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.